The drug was first approved in 2010 as a treatment for adults with schizophrenia, as well as adults experiencing major depressive episodes associated with bipolar I disorder.
Latuda is the first medication to be approved for adolescent patients with schizophrenia in five years, according to a news release.
More articles on supply chain:
Mylan CEO speaks out for 1st time since congressional hearing: 5 quotes
Target launches new guidelines to control chemicals in its supply chain
Shark antibodies could successfully transport drugs to brain
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
